Vivanza Biosciences Ltd. Press Release Aug 08 2026

Pursuant to Regulation 32 of the SEBI(LODR) Regulation, 2015 Read with SEBI circular dated 24th December, 2019 regarding the submission of the statement of deviation or variation from the proceeds of public issue/rights issue/preferential issue, qualified institutional placement etc. we hereby confirm that the company has not raised any further funds by means of Public Issue, rights issue or preferential issue etc. hence the statement of deviation and variation is not applicable to the company.

View Attachment